OTC Markets OTCQX - Delayed Quote USD

MariMed Inc. (MRMD)

Compare
0.1600 +0.0050 (+3.23%)
As of 2:28 PM EDT. Market Open.
Loading Chart for MRMD
DELL
  • Previous Close 0.1550
  • Open 0.1550
  • Bid 0.1550 x --
  • Ask 0.1600 x --
  • Day's Range 0.1550 - 0.1690
  • 52 Week Range 0.1380 - 0.4100
  • Volume 184,350
  • Avg. Volume 457,525
  • Market Cap (intraday) 60.898M
  • Beta (5Y Monthly) 2.80
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date Nov 6, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.40

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

www.marimedinc.com

643

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MRMD

View More

Performance Overview: MRMD

Trailing total returns as of 10/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MRMD
41.82%
S&P 500
22.93%

1-Year Return

MRMD
58.12%
S&P 500
35.48%

3-Year Return

MRMD
81.00%
S&P 500
34.37%

5-Year Return

MRMD
79.87%
S&P 500
97.41%

Compare To: MRMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MRMD

View More

Valuation Measures

Annual
As of 10/11/2024
  • Market Cap

    58.99M

  • Enterprise Value

    136.34M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.37

  • Price/Book (mrq)

    0.84

  • Enterprise Value/Revenue

    0.87

  • Enterprise Value/EBITDA

    17.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.13%

  • Return on Assets (ttm)

    2.89%

  • Return on Equity (ttm)

    -18.21%

  • Revenue (ttm)

    156.07M

  • Net Income Avi to Common (ttm)

    -17.38M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.19M

  • Total Debt/Equity (mrq)

    99.93%

  • Levered Free Cash Flow (ttm)

    6.74M

Research Analysis: MRMD

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 40.44M
Earnings -1.65M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

0.40
0.40 Average
0.1600 Current
0.40 High
 

Company Insights: MRMD

People Also Watch